Abby S Van Voorhees

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Depression and quality of life in psoriasis
    Abby S Van Voorhees
    Psoriasis and Phototherapy Treatment Center, University of Pennsylvania, Dept of Dermatology, Philadelphia, PA 19104, USA
    Postgrad Med 121:154-61. 2009
  2. ncbi request reprint AAD Guidelines of Care: how did we get here and where are we going?
    Abby S Van Voorhees
    Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19404, USA
    J Am Acad Dermatol 48:978-80. 2003
  3. pmc Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis
    Howa Yeung
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Acad Dermatol 68:64-72. 2013
  4. pmc Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis
    Katrina Abuabara
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Acad Dermatol 68:262-9. 2013
  5. pmc Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting
    Joel M Gelfand
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    Arch Dermatol 148:487-94. 2012
  6. doi request reprint Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation
    Kavita Menon
    Department of Dermatology, New York University, New York, New York 10016 6497, USA
    J Am Acad Dermatol 62:291-9. 2010
  7. pmc Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients
    Joy Wan
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Acad Dermatol 66:376-86. 2012
  8. doi request reprint Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation
    Robert E Kalb
    Department of Dermatology, State University of New York School of Medicine and Biomedical Sciences, Buffalo, New York, USA
    J Am Acad Dermatol 60:120-4. 2009
  9. doi request reprint Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation
    Samuel Bremmer
    Department of Dermatology, Oregon Health and Science University, Portland, Oregon, USA
    J Am Acad Dermatol 63:1058-69. 2010
  10. doi request reprint Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation
    Misha Rosenbach
    Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Am Acad Dermatol 62:655-62. 2010

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Depression and quality of life in psoriasis
    Abby S Van Voorhees
    Psoriasis and Phototherapy Treatment Center, University of Pennsylvania, Dept of Dermatology, Philadelphia, PA 19104, USA
    Postgrad Med 121:154-61. 2009
    ..Physicians managing patients with psoriasis must be aware of the psychological effects of psoriasis and need to use a multifaceted approach to managing this disease, focusing on both the physical and psychological aspects...
  2. ncbi request reprint AAD Guidelines of Care: how did we get here and where are we going?
    Abby S Van Voorhees
    Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19404, USA
    J Am Acad Dermatol 48:978-80. 2003
    ..We believe that these guidelines continue to serve as effective educational tools for dermatologists around the world...
  3. pmc Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis
    Howa Yeung
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Acad Dermatol 68:64-72. 2013
    ..Despite widespread dissatisfaction and low treatment persistence in moderate to severe psoriasis, patients' reasons behind treatment discontinuation remain poorly understood...
  4. pmc Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis
    Katrina Abuabara
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Acad Dermatol 68:262-9. 2013
    ..Physician perceptions can influence prescribing patterns and patient outcomes, and may help to explain variations in clinical practice...
  5. pmc Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting
    Joel M Gelfand
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    Arch Dermatol 148:487-94. 2012
    ..To compare the effectiveness of biologic systemic therapy, nonbiologic systemic therapy, and phototherapy for treatment of psoriasis...
  6. doi request reprint Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation
    Kavita Menon
    Department of Dermatology, New York University, New York, New York 10016 6497, USA
    J Am Acad Dermatol 62:291-9. 2010
    ..Therefore, therapy for the HIV-infected patient is more challenging, requiring both careful consideration of the potential risks and benefits of treatment and more fastidious monitoring for potential adverse events...
  7. pmc Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients
    Joy Wan
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Acad Dermatol 66:376-86. 2012
    ..Despite increasing therapies for moderate to severe psoriasis, dermatologists' treatment preferences are unknown...
  8. doi request reprint Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation
    Robert E Kalb
    Department of Dermatology, State University of New York School of Medicine and Biomedical Sciences, Buffalo, New York, USA
    J Am Acad Dermatol 60:120-4. 2009
    ..Involvement of areas of the skin fold is common in patients with psoriasis although the exact incidence is unknown. This report summarizes studies regarding the therapy of intertriginous psoriasis...
  9. doi request reprint Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation
    Samuel Bremmer
    Department of Dermatology, Oregon Health and Science University, Portland, Oregon, USA
    J Am Acad Dermatol 63:1058-69. 2010
    ..Efficacy and safety concerns affected by obesity are important considerations for clinicians who are making decisions on proper treatment of psoriasis...
  10. doi request reprint Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation
    Misha Rosenbach
    Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Am Acad Dermatol 62:655-62. 2010
    ..There are a number of treatment options, but overall there are few evidence-based data to guide clinicians in managing these challenging cases...
  11. doi request reprint Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation
    Yoon Soo Cindy Bae
    Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA
    J Am Acad Dermatol 67:459-77. 2012
    ....
  12. doi request reprint Consensus guidelines for the management of plaque psoriasis
    Sylvia Hsu
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA
    Arch Dermatol 148:95-102. 2012
    ....
  13. doi request reprint Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation
    C Stanley Chan
    Department of Dermatology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Am Acad Dermatol 60:962-71. 2009
    ..The scalp is the most commonly affected part of the body in patients with psoriasis. Signs and symptoms of scalp psoriasis vary significantly for individual patients...
  14. doi request reprint Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation
    Amylynne J Frankel
    Department of Dermatology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    J Am Acad Dermatol 61:1044-55. 2009
    ....
  15. pmc Long-term efficacy of biologics in dermatology
    Leslie Castelo-Soccio
    Department of Dermatology, University of Pennsylvania, 3600 Spruce Street, Philadelphia, PA 19104, USA
    Dermatol Ther 22:22-33. 2009
    ..The studies supporting the use of rituximab and intravenous immunoglobulin in autoimmune blistering diseases are also presented in this review...
  16. doi request reprint From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis
    Lara Wine-Lee
    Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    J Am Acad Dermatol 69:1003-13. 2013
    ....
  17. doi request reprint Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics
    Alice Gottlieb
    Department of Dermatology, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
    J Am Acad Dermatol 58:851-64. 2008
    ..We will discuss the use of disease-modifying antirheumatic drugs and the biologic therapies in the treatment of patients with moderate to severe psoriatic arthritis...
  18. ncbi request reprint National Psoriasis Foundation clinical consensus on disease severity
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    Arch Dermatol 143:239-42. 2007
    ....
  19. pmc TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation
    Brian S Kim
    Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Sci Transl Med 5:170ra16. 2013
    ..Collectively, these results demonstrate an essential role for IL-33- and IL-25-independent group 2 ILCs in promoting skin inflammation...
  20. pmc Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study
    Nehal N Mehta
    Cardiovascular Institute, University of Pennsylvania School of Medicine, 6 Penn Tower, Philadelphia, PA 19104, USA
    Arch Dermatol 147:1031-9. 2011
    ..To evaluate the feasibility of using [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) to detect and quantify systemic inflammation in patients with psoriasis...
  21. ncbi request reprint Guidelines of care for acne vulgaris management
    John S Strauss
    Department of Dermatology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, USA
    J Am Acad Dermatol 56:651-63. 2007
    ..The ultimate judgment regarding the propriety of any specific therapy must be made by the physician and the patient in light of all the circumstances presented by the individual patient...
  22. ncbi request reprint Epstein-Barr virus and human herpesvirus type 6 infection in patients with psoriasis
    Andrea L Neimann
    Department of Dermatology, University of Pennsylvania, 3600 Spruce Street, 2 Maloney Building, Philadelphia, PA 19104, USA
    Eur J Dermatol 16:548-52. 2006
    ..11). The results of this study suggest that neither severe psoriasis alone, nor in combination with immunosuppressive therapy, is associated with an increase in Epstein-Barr virus or human herpesvirus 6 replication in white blood cells...
  23. ncbi request reprint Narrowband ultraviolet B therapy for psoriasis and other skin disorders
    Joseph M Kist
    Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Adv Dermatol 21:235-50. 2005
  24. ncbi request reprint Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines"
    Jon M Hanifin
    American Academy of Dermatology, PO Box 4014, Schaumburg, IL 60168 4014, USA
    J Am Acad Dermatol 50:391-404. 2004